Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.
DNA-dependent protein kinase (DNA-PK) binds to strand breaks produced during normal cellular processes or in response to genotoxic stresses, such as ionizing radiation, targeting substrates that facilitate DNA repair. NU 7026 is a cell-permeable, potent, specific, and ATP-competitive inhibitor of DNA-PK (IC50 = 230 nM).1 It poorly inhibits phosphioinositide 3 kinase (IC50 = 13 μM) and is inactive against ataxia telangiectasia mutated kinase, ATR, and poly (ADP-ribose) polymerase.1 NU 7026 impairs cellular DNA double strand break repair and decreases survival in cells exposed to ionizing radiation.1 It also potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia. For example, it potentiates the growth inhibitory effects of mitoxantrone in K562 cells more than 10-fold.2
1
Veuger, S.J., Curtin, N.J., Richardson, C.J., et al. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1. Cancer Res636008-6015(2003).
2
Willmore, E., de Caux, S., Sunter, N.J., et al. Anovel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia. Blood103(12)4659-4665(2004).
Room temperature
in continental US; may vary elsewhere
SMILES
Copy SMILES to clipboard
O=c1cc(oc2c1ccc1ccccc21)N1CCOCC1
Background Reading
Willmore, E., de Caux, S., Sunter, N.J., et al. Anovel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia. Blood103(12)4659-4665(2004).
Veuger, S.J., Curtin, N.J., Richardson, C.J., et al. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1. Cancer Res636008-6015(2003).
Size
Price
Quantity
Subtotal
5 mg
$65.00
$0.00
10 mg
$124.00
$0.00
25 mg
$293.00
$0.00
50 mg
$520.00
$0.00
Bulk
Contact
Cart Total
$0.00
This product is available in custom sizes and/or larger quantities.